Pluri Inc. Fair Value Adjustment of Warrants
Pluri Inc. (PLUR) reported Fair Value Adjustment of Warrants of -$556.00 thousand for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-17.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2025-09-17
- Pluri Inc. fair value adjustment of warrants for the quarter ending 2025-06-30 was -$539.00K.
- Pluri Inc. fair value adjustment of warrants for the quarter ending 2025-03-31 was -$17.00K.
- Pluri Inc. fair value adjustment of warrants for fiscal 2025 was -$556.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$539.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17 | -$556.00K derived: sum of 2 quarters · filed 2025-09-17 | -$556.00K 10-K · filed 2025-09-17 | |
| 2025-03-31 | -$17.00K 10-Q · filed 2025-05-13 | -$17.00K 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |